Analyst Consensus ?
ConsensusHold37 ratings
Bullish1746.0%
Neutral1745.9%
Bearish38.1%
UDR, Inc. · UDR · FY2026 Q1 · Calendar Q2 2026
UDR Holds Guidance as Occupancy and Retention Drive Q1; Monthly Dividend Unveiled
UDR delivered Q1 2026 results consistent with management's full-year framework, anchored by 97% occupancy and 5.2% renewal rate growth. The headline initiative was a pioneering monthly dividend designed to broaden the shareholder base to retail and high-net-worth investors. Capital allocation remained active with $150M in share repurchases funded by $362M in asset sales, alongside a new Portland, Oregon acquisition. Despite a modest revenue miss versus consensus, management reiterated full-year guidance unchanged, signaling confidence in demand fundamentals and limited new apartment supply. The stock's slight post-earnings underperformance (-0.5% abnormal) followed by modest positive drift suggests the market viewed results as steady rather than surprising.
Reported After market closeNYSEReal Estate
$12.44B market cap
100quality score
Company context
Snapshot as of publicationUDR, Inc. (NYSE: UDR), a distinguished S&P 500 company, stands as a premier multifamily real estate investment trust. The company boasts a proven history of generating exceptional and reliable returns for its investors, achieving this through the astute management, acquisition, disposition, development, and redevelopment of appealing real estate properties situated in key U.S. markets. As of September 30, 2020, UDR's extensive portfolio included ownership or partial ownership in 51,649 apartment homes, with an additional 1,031 units currently under development. With over 48 years in operation, UDR has consistently delivered long-term value to its shareholders, provided superior service to its residents, and fostered a high-quality experience for its associates.
Earnings scorecard
Reported versus consensus
Reported EPS
$0.57
Consensus $0
EPS surprise
+377.4%
Reported versus consensus
Reported revenue
$423.3M
Consensus $427.1M
Revenue surprise
-0.9%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$37.78Current
$35Low
$44.93Average
$64High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 28, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 22, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Jul 21, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 14, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Jul 9, 2026 |
| Truist Securities | Hold | Buy | Downgrade | Jul 8, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 25, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jun 10, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 6, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 6, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | May 4, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Apr 17, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Feb 17, 2026 |
| UBS | Buy | Buy | Maintain | Jan 8, 2026 |
| JP Morgan | Underweight | Neutral | Downgrade | Dec 18, 2025 |
| Zelman & Assoc | Neutral | Outperform | Downgrade | Feb 13, 2025 |
| Wedbush | Outperform | Outperform | Maintain | Aug 5, 2024 |
| BMO Capital | Outperform | Market Perform | Upgrade | Jul 15, 2024 |
| Baird | Outperform | Outperform | Maintain | Mar 12, 2024 |
| Keybanc | Overweight | Overweight | Maintain | Dec 13, 2023 |
| B of A Securities | Neutral | Buy | Downgrade | Oct 31, 2023 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | May 15, 2023 |
| Jefferies | Buy | Buy | Maintain | Oct 19, 2022 |
| Capital One | Overweight | Equal Weight | Upgrade | Nov 16, 2021 |
| BTIG | Buy | Neutral | Upgrade | Sep 13, 2021 |
| Stifel | Buy | Buy | Maintain | May 8, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Apr 2, 2020 |
| Capital One Financial | Overweight | Equal Weight | Upgrade | Sep 16, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Sep 25, 2018 |
| Bank of America | Buy | Buy | Maintain | Jun 8, 2018 |
| BTIG Research | Neutral | Buy | Downgrade | Jun 30, 2017 |
| JMP Securities | Market Perform | Market Outperform | Downgrade | Jan 19, 2016 |
| Cowen & Co. | Market Perform | Outperform | Downgrade | Jan 12, 2016 |
| Miller Tabak | Sell | Hold | Downgrade | Nov 9, 2015 |
| Credit Suisse | Neutral | Underperform | Upgrade | Oct 27, 2015 |
| ISI Group | Buy | Neutral | Upgrade | Nov 18, 2013 |
| Compass Point | Neutral | Neutral | Maintain | Aug 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $37.78. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Goldman Sachs | Julien Blouin | $38 | $38.3 | +0.6% | Jul 30, 2026 |
| Wells Fargo | Analyst unavailable | $44 | $39.57 | +16.5% | Jul 22, 2026 |
| Deutsche Bank | Peter Abramowitz | $45 | $39.74 | +19.1% | Jul 20, 2026 |
| Barclays | Richard Hightower | $46 | $40.18 | +21.8% | Jul 14, 2026 |
| Scotiabank | Nicholas Yulico | $41 | $39.79 | +8.5% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $41 | $39.37 | +8.5% | Jun 10, 2026 |
| Scotiabank | Analyst unavailable | $38 | $37.52 | +0.6% | May 14, 2026 |
| Barclays | Analyst unavailable | $41 | $36.91 | +8.5% | May 11, 2026 |
| Cantor Fitzgerald | Richard Anderson | $39 | $36.39 | +3.2% | May 4, 2026 |
| Goldman Sachs | Analyst unavailable | $35 | $34.25 | -7.4% | Apr 17, 2026 |
| Piper Sandler | Analyst unavailable | $41 | $38.09 | +8.5% | Feb 17, 2026 |
| Goldman Sachs | Analyst unavailable | $39 | $38.17 | +3.2% | Feb 12, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $42 | $39.38 | +11.2% | Feb 11, 2026 |
| RBC Capital | Brad Heffern | $39 | $39.38 | +3.2% | Feb 10, 2026 |
| Goldman Sachs | Julien Blouin | $37.5 | $37.64 | -0.7% | Jan 20, 2026 |
| UBS | Michael Goldsmith | $42 | $36.82 | +11.2% | Jan 8, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $37 | $36.55 | -2.1% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $41 | $36.42 | +8.5% | Dec 1, 2025 |
| Barclays | Analyst unavailable | $44 | $35.63 | +16.5% | Nov 25, 2025 |
| Mizuho Securities | Analyst unavailable | $38 | $35.59 | +0.6% | Nov 24, 2025 |
| Goldman Sachs | Analyst unavailable | $33 | $33.79 | -12.7% | Nov 4, 2025 |
| Piper Sandler | Analyst unavailable | $39 | $33.69 | +3.2% | Nov 3, 2025 |
| Evercore ISI | Analyst unavailable | $44 | $35.71 | +16.5% | Oct 13, 2025 |
| Wells Fargo | Analyst unavailable | $41 | $35.71 | +8.5% | Oct 13, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $40 | $37.26 | +5.9% | Oct 1, 2025 |
| Barclays | Analyst unavailable | $45 | $36.94 | +19.1% | Sep 30, 2025 |
| Evercore ISI | Steve Sakwa | $45 | $38.37 | +19.1% | Sep 15, 2025 |
| BMO Capital | Analyst unavailable | $44 | $38.39 | +16.5% | Sep 4, 2025 |
| Truist Financial | Michael Lewis | $43 | $38.95 | +13.8% | Aug 26, 2025 |
| Morgan Stanley | Adam Kramer | $44.5 | $37.83 | +17.8% | Aug 13, 2025 |
| Evercore ISI | Steve Sakwa | $46 | $40.8 | +21.8% | Jul 7, 2025 |
| RBC Capital | Brad Heffern | $46 | $45.34 | +21.8% | Oct 1, 2024 |
| Evercore ISI | Steve Sakwa | $43 | $44.05 | +13.8% | Sep 9, 2024 |
| Goldman Sachs | Julien Blouin | $42 | $44.92 | +11.2% | Sep 4, 2024 |
| Evercore ISI | Steve Sakwa | $42 | $43.64 | +11.2% | Aug 28, 2024 |
| Piper Sandler | Alexander Goldfarb | $46 | $43.3 | +21.8% | Aug 26, 2024 |
| BMO Capital | Juan Sanabria | $45 | $40.56 | +19.1% | Jul 15, 2024 |
| Robert W. Baird | Amanda Sweitzer | $42 | $39.02 | +11.2% | May 24, 2024 |
| Scotiabank | Nicholas Yulico | $42 | $39.28 | +11.2% | May 14, 2024 |
| Scotiabank | Sector Perform | $39 | $38.08 | +3.2% | May 1, 2024 |
| UBS | Michael Goldsmith | $44 | $37.89 | +16.5% | Apr 25, 2024 |
| Piper Sandler | Alexander Goldfarb | $40 | $37.87 | +5.9% | Apr 10, 2024 |
| Truist Financial | Michael Lewis | $42 | $37.63 | +11.2% | Apr 9, 2024 |
| Wells Fargo | James Feldman | $39 | $37.28 | +3.2% | Mar 4, 2024 |
| UBS | Michael Goldsmith | $43 | $38.04 | +13.8% | Sep 19, 2023 |
| Scotiabank | Nicholas Yulico | $45 | $40.19 | +19.1% | Aug 30, 2023 |
| Scotiabank | Nicholas Yulico | $58 | $46.48 | +53.5% | May 19, 2022 |
| Piper Sandler | Alexander Goldfarb | $57 | $51.83 | +50.9% | May 4, 2022 |
| Truist Financial | Michael R Lewis | $59 | $56.75 | +56.2% | Dec 6, 2021 |
| Wells Fargo | Tammi Fique | $61 | $54.93 | +61.5% | Nov 22, 2021 |
| Capital One Financial | Neil Malkin | $64 | $55.43 | +69.4% | Nov 16, 2021 |
| Morgan Stanley | Richard Hill | $59.5 | $54.19 | +57.5% | Nov 8, 2021 |
| Goldman Sachs | Chandni Luthra | $60 | $52.95 | +58.8% | Sep 23, 2021 |
| Piper Sandler | Alexander Goldfarb | $58 | $54.23 | +53.5% | Sep 1, 2021 |
Track every rating change on UDR the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
+0.5%
Event window
SPY move
+1.0%
Same window
Abnormal move
-0.5%
Stock minus SPY
Volume
2.3×
Versus trailing sessions
Subsequent drift
+1.5%
Up to 20 sessions
UDRSPY benchmark
Follow UDR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Q1 2026 results met internal guidance with 97% occupancy, 5.2% renewal rate growth, and 1.6% blended lease-rate growth. UDR became the first residential REIT to adopt a monthly dividend. The company sold four assets for $362M, repurchased $150M of stock, and acquired a 232-unit Portland community. The Riverside, CA ground-up development (3099 Iowa) is now expected to be occupied in 2026, a year ahead of schedule and under budget. Sunbelt lease-rate growth softened in April but management expects recovery.
Guidance delta
Full-year 2026 guidance was reiterated unchanged, consistent with the prior quarter's framework targeting 1.5-2% lease-rate growth and 0.25-2.25% same-store revenue growth. Guidance sentiment is maintained.
Key takeaways
- Q1 results met guidance with 97% occupancy, 5.2% renewal rate growth, and 1.6% blended lease-rate growth
- UDR became the first residential REIT to adopt a monthly dividend distribution to broaden the shareholder base
- Capital allocation included $150M of share repurchases, $362M in asset sales, and acquisition of a 232-unit Portland community
- The 3099 Iowa development in Riverside, CA is ahead of schedule and under budget, with occupancy expected in 2026
- Liquidity remains robust at over $1B and full-year guidance is unchanged
Management priorities
- Continue monthly dividend payments and shareholder outreach to expand the investor base
- Pursue additional share repurchases funded by future asset dispositions
- Complete acquisition of a second Portland asset and integrate it into the portfolio
- Accelerate the Riverside, CA development timeline and monitor land-bank opportunities
- Maintain data-driven operational enhancements to boost revenue and cash flow
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-31T14:01:14.831192+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-31T14:01:14.828912+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.